No well-defined Blastomyces-specific antigens are currently available. We used sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting to identify immunologically active molecules in the cell wall of B. dermatitidis. A major immunoreactive 120-kD protein (WI-1) was present in all five strains studied and comprised 5% of the protein in the cell wall extract obtained after freezing and thawing yeast cells. WI-1 was recognized by serum from all 10 patients with blastomycosis but by none of those from 5 patients with histoplasmosis. It was purified by electroelution, radiolabeled with 1II, and incorporated into a radioimmunoassay (RIA) for serodiagnosis of blastomycosis. Antibody to WI-1 was detected in 58 (85%) 
Introduction
Blastomycosis, one of the principal endemic systemic mycoses, derives from infection with the thermal dimorphic fungus, Blastomyces dermatitidis. Humans and other animals such as dogs are primarily infected by inhaling aerosolized conidia from soil, where the organism dwells as a saprophyte (1) . At body temperature, the conidia convert to yeast forms Presented in part at the 28th Interscience Conference on Antimicrobial that can be distinguished from other yeasts by their large size (up to 30 ,gm), refractile cell wall, and broad-based buds. The acute primary pulmonary infection can be asymptomatic or can produce an influenza or atypical pneumonia syndrome (2) . Although acute blastomycotic pneumonia may resolve spontaneously, progressive forms of disease involving the lungs, extrapulmonary organs (usually skin, bones, joints or prostate gland), or both develop in many patients.
Although serologic and skin tests play an important role in the identification and epidemiologic study of other systemic mycoses, especially histoplasmosis and coccidioidomycosis, reliable immune markers of recent and remote B. dermatitidis infection are not generally available for noninvasive diagnosis and study of the epidemiologic features of blastomycosis. Two antigens ofyeast form B. dermatitidis have been described and employed in diagnostic tests: A antigen (serodiagnosis) (3) and Blastomyces alkali-and water-soluble antigen or B-ASWS (in vitro lymphocyte proliferation) (4) . Both antigens are impure (5, 6) , they appear to be a mixture ofcell wall components, and tests employing them are not widely available. A further problem with serologic tests using A antigen has been diminished specificity as sensitivity is increased by enzyme immunoassay techniques (7) (8) (9) . This problem results from A-antigen impurity and the extensive sharing of cell wall components between dimorphic fungi, particularly B. dermatitidis and Histoplasma capsulatum.
Previous cell wall composition studies of B. dermatitidis yeasts have shown that an a--1,3-glucan comprises nearly 95% of the polymeric glucose and a fl-1,3-glucan comprises the remaining portion; chitin comprises -37% of the wall (10, 11) . Advances in the characterization of microbial polysaccharases specific for a-1,3-glucans, fl-1,3-glucans, and chitin have allowed us to design a rational and comprehensive digestion scheme to investigate the cell wall ofB. dermatitidis yeasts for immunologically relevant molecules. We describe here the isolation and partial purification and characterization of a 120-kD surface protein that appears to be uniquely expressed on B. dermatitidis yeasts and is distinct from components in A-antigen and B-ASWS. We further show that the 120-kD molecule, which we have designated WI-1, can be radiolabeled with 1251 to reliably detect antibody in infected patients by radioimmunoassay.
Methods
Fungi. Five American Type Culture Collection (ATCC) strains of B. dermatitidis (kindly provided by Dr. Arthur DiSalvo, South Carolina Bureau of Laboratories, Columbia, SC) were studied: 60636, 60637, 26198, 32090, and 26199. The first three strains are soil isolates, 60636 and 60637 having been isolated in association with epidemics of human disease in Wisconsin (12, 13) , and the latter strains are human isolates. Stock cultures were maintained in the yeast form on 7H10 agar enriched with oleic acid-albumin complex (Sigma Chemical Co., St . Louis, MO) at 370C. Yeasts were grown in Erlenmeyer flasks containing brain heart infusion (BHI)' broth (Difco Laboratories, Detroit, MI) at 370C in a gyrator shaker at 120 rpm for 72 h.
Other fungi studied were Candida albicans strain B3 1 1-A (ATCC 32354) and a clinical isolate of H. capsulatum (kindly provided by James Stoebig, Mycology Section, Wisconsin State Laboratory of Hygiene, Madison). C. albicans was maintained on slants of Sabouraud dextrose agar. Yeasts were grown in Erlenmeyer flasks containing the medium of Lee et al. (14) at 240C in a gyratory shaker at 100 rpm for 24 h. H. capsulatum was maintained on slants of BHI agar containing 2% L-glutamine, 10% citric acid, and 10% defribinated sheep blood. Yeasts were grown in Erlenmeyer flasks containing BHI broth at 370C in a gyratory shaker at 120 rpm for 72 h.
All yeasts were harvested by filtration through a sintered glass filter and washed three times with saline. Freshly grown yeasts were used in experiments unless otherwise stated, in which case yeasts that had been stored at -20'C in 20 mM Tris-HCI, pH 6.8, containing 1 Extraction ofB. dermatitidis. Serial extraction of the cell wall was performed as follows. Yeasts that had been stored at -20'C were thawed and centrifuged at 600 g for 10 min, and the supernatant, which we termed freeze extract, was removed. 10 ml of wet-pelleted organisms were suspended in 10 volumes offresh 20 mM Tris-HCI, pH 6.8, containing 1 mM MgCI2 and 5,000 U of mutanolysin (Sigma Chemical Co.), an enzyme product of Streptomyces globisporus (15, 16) with activity for a-1,3-glucan linkages. The suspension was incubated overnight in a shaking water bath at 37°C and centrifuged at 600 g for 10 min, and the supernatant was removed. Pelleted, mutanolysin-treated yeasts were suspended (200 mg/ml) in 0.6 M KCI, 0.04 M NaH2PO4, pH 6.0, containing 7 mM 2-mercaptoethanol and 0.25 mg/ml chitinase and 10,000 U/ml ,B-glucuronidase (both from Sigma Chemical Co.). The suspension was incubated in a shaking water bath at 32°C for 1 h and centrifuged at 600 g for 10 min. The supernatant was removed and heated in a shaking water bath at 56°C for 1 h.
To prepare a cytoplasmic extract, 15 ml of freshly grown, washed yeast cells were suspended in 35 ml of Tris buffer and the suspension was passed through a French pressure cell at 1,100 kg/cm2. Cellular debris was removed from the effluent by centrifuging at 12,000 g for 30 min.
Supernatants removed after cell wall and cytoplasmic extractions were dialyzed for 48 h against deionized-distilled water in nitrogenpurged dialysis tubing with a 3,500-mol wt exclusion. Dialysates were Iyophilized to obtain dry extracts. The protein content of extracts was estimated using the BCA protein assay reagent (Pierce Chemical Co., Rockford, IL) with BSA (nitrogen, 15.4%) as a standard. Lactic dehydrogenase (LDH) activity in extracts, which was used as a marker of the cytoplasmic origin of material, was determined using the method of Wroblewski and LaDue (17) . 1 Japan). For scanning EMs, the treated yeast suspension was criticalpoint dried, coated with gold, and examined in a scanning electron microscope (JSM-U3; JEOL Corp., Peabody, MA).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Samples were prepared for SDS-PAGE analysis by dissolving an extract at a concentration of 40 mg (dry wt)/ml in sample buffer containing 0.125 M Tris-HCI, 4% (wt/vol) SDS, 2% (wt/vol) glycerol, and 10% (vol/vol) 2-mercaptoethanol (pH 6.8). After boiling for 2 min, samples were electrophoresed on 10% SDS-PAGE slab gels as described by Laemmli (18). Gels were stained for protein with Coomassie brilliant blue or silver nitrate (19) and for carbohydrate by the periodic acid-Schiff(PAS) method (20) .
Western blots. Upon completion of SDS-PAGE, Western blots of gels were prepared as described by Towbin et al. (21) . Nitrocellulose paper was placed on the gel in a cassette in a Transphor electrophoresis chamber (Hoefer Scientific Instruments, San Francisco, CA) filled with 20 mM Tris base containing 150 mM glycine and 20% (vol/vol) methanol. Gel components were transferred to the nitrocellulose paper by passing a current transversely across the cassette for 18 h at 70 V. The nitrocellulose was placed in a solution of 3% BSA in Tris-buffered saline (TBS) (BSA-TBS; 50 mM Tris-HCI, 200 mM NaCl [pH 7.4]) at 40'C to saturate unoccupied sites on the paper with albumin. The paper was cut vertically into strips and a strip was incubated for 2 h at room temperature with the desired serum diluted 1:10 in TBS. Strips were washed in six changes of saline (5 min each) and exposed to the appropriate conjugate, either peroxidase-conjugated sheep anti-rabbit IgG or peroxidase-conjugated rabbit anti-human IgG (Cooper Biomedical, Inc., West Chester, PA). Conjugates were diluted 1:2,000 in saline containing 3% (wt/vol) BSA and 10% (vol/vol) fetal calf serum. The above technique was modified slightly for miniblots. After unoccupied sites on the nitrocellulose were saturated with albumin, the uncut paper was placed into a 48-lane miniblotting apparatus (Immunetics, Inc., Boston, MA). Reagents and steps were otherwise the same as above.
Partial purification ofprotein antigen. An electrophoretic concentrator (Isco, Inc., Lincoln, NE) was used to elute and concentrate WI-I from crude cell-wall extracts. After an extract was separated on a 10% SDS-PAGE gel, the location of WI-I was estimated from knowledge of its molecular weight and the location in the gel ofprestained molecular weight markers. An 0.5-cm horizontal strip was cut from the unstained gel corresponding to the 1 18-kD molecular weight marker, ,B-galactosidase. The gel strip was cut into pieces and placed in a transparent polycarbonate sample cup having a small and a large well that contained a 1:10 dilution of 25 mM Tris-base, pH 8.3, and 192 mM glycine; the cup in turn was bathed in a buffer tank containing the undiluted buffer. 3 W were applied across the buffer tank for 4 h to elute WI-1 from the gel and concentrate it in 250 a1 of buffer in the small well, whose base was covered with a membrane having a 3,500-mol wt exclusion. This eluate was further concentrated by centrifugation at 5,000 g for 30 min in a Centricon tube (Amicon Corp., Danvers, MA). The purity of the eluate was assessed by SDS-PAGE, and the protein content by using the Pierce reagent.
RIA. Target antigen in the RIA was labeled with '25I using Nchlorobenzenesulfonamide as an oxidizing agent (22) . By adjusting labeling conditions, we could vary the specific radioactivity of 125IWI_ 1 between 2,000 and 10,000 cpm/ng. When labeled to a specific radioactivity of 2,000 cpm/ng, the capacity of 125IWI_ I to bind specific antibody was stable for at least I mo. Counting efficiency of the gamma counter was 60%.
We used 1% BSA in 0.04 M NaH2PO4, 0.15 M NaCI, pH 7.5 (PBS) as the carrier solution in the RIA. All sera being tested were diluted serially in BSA-PBS in flat-bottom, 96-well microtiter plates (Costar, Cambridge, MA). Dilutions of 1:40 and greater were tested. Each experimental or control serum sample was analyzed in duplicate. A test sample consisted of 0.1 ml of diluted serum and 0.1 ml of BSA-PBS containing 5 ng of 125IWI-1. Coprecipitation controls for antibody measurements contained 0.1 ml of BSA-PBS in place of diluted test serum. After incubating for I h at 370C and overnight at 4VC, I mg of staphylococcal protein A (Sigma) in 0.2 ml of PBS was added to each sample. Precipitates were centrifuged at 2,000 g for 10 min at room temperature and 0.2 ml of each supernatant was counted in a gamma counter.
Coprecipitation was corrected for in all RIAs by the method of Minden and Farr (23) . Coprecipitation never exceeded 10% of labeled antigen added and was usually under 5%. The dilution of each test serum that specifically bound 20% of the labeled antigen dose was calculated by linear regression analysis (22) , using the data points of the three dilutions that gave binding values closest to 20%. A standard lot of rabbit antiserum derived by immunizing the animal with unlabeled WI-I was assayed with each run of experimental sera titered for antibody to the labeled antigen. This insured that there was no significant run-to-run variation in the sensitivity of the assay. Based on six determinations of the specific antibody level in the standard rabbit antiserum, the standard deviation of the mean of these values, +2%, was taken as a measure of the precision of the RIA to measure the antibody.
The RIA was used to quantitate the amount ofWI-I on the surface of B. dermatitidis (strain 60636), H. capsulatum and C. albicans yeasts. The specific inhibition of binding of '25I-WI-I to diluted rabbit antiserum was measured for unlabeled WI-1 and these yeasts. Each assay tube contained 0. Experimental and control serum samples. Human sera tested were from patients with endemic or epidemic-related cases of blastomycosis, histoplasmosis, coccidioidomycosis, sporotrichosis, or candidiasis and from healthy persons (Table I) . Clinical information was available in all 68 patients with blastomycosis and in 63 (86%) of 73 control subjects with other fungal diseases. 34 blastomycosis patients had acute pulmonary infection, 22 had chronic pulmonary disease, 9 had chronic pulmonary and extrapulmonary disease, and 3 had isolated cutaneous disease. 10 histoplasmosis patients had acute pulmonary infection, 10 had chronic pulmonary disease, and 4 had disseminated disease; no clinical information was available in the remaining 10 histoplasmosis patients. 7 coccidioidomycosis patients had acute pulmonary infection, 5 had chronic pulmonary disease, and 10 had disseminated disease. 10 sporotrichosis patients had isolated cutaneous disease and 1 had cavitary pulmonary disease. The six candidiasis patients had invasive infection in association with hematologic malignancy. Most sera were stored at -70°C for up to 4 yr; however, those from Arkansas patients with blastomycosis had been stored at -20°C. Many sera from Wisconsin patients with blastomycosis had been thawed and refrozen at least three times.
Rabbit antiserum was produced in a New Zealand white rabbit immunized with 5-.ug doses of WI-I in 0.5 ml sterile deionized, distilled water. Subcutaneous injections were given weekly for 4 wk in 0.5 ml complete Freund adjuvant, and then biweekly in 0. anti-rabbit IgG (Cappel Laboratories, Cochranville, PA) diluted 1:160 in PBS containing 0.05% (wt/vol) Tween 20 and 0.05% (wt/vol) Evans blue was added to each well and slides were again incubated at 370C for 30 min in a humidified container. Slides were again rinsed in PBS and air dried. Carbonate-glycerol, pH 9, was added to each well and a coverslip was applied. Slides were examined under oil immersion at X 100 using a microscope equipped to detect reflected fluorescence (BH-2; Olympus Optical Co., Tokyo, Japan).
For immunogold staining, 107 fresh B. dermatitidis yeast cells were suspended in 1 ml of BSA-PBS at room temperature for 15 min using constant rotation. Samples were centrifuged at 600 g for 5 min and the supernatant was removed. Preimmune, immune, or WI-1 antigen-and yeast-adsorbed immune serum was serially diluted in BSA-PBS and 1 ml ofeach dilution or ofBSA-PBS as a control was added to the sample of yeasts. Serum dilutions of 1:100 and greater were tested. Samples were incubated at room temperature for 2 h using constant rotation. Yeasts were washed in PBS and centrifuged three times. Protein A-gold containing 14-nm particles was prepared using the method of Lucocq and Roth (25) . It was diluted 1:15 in BSA-PBS and 1 ml added to each sample of yeasts. Samples were incubated at room temperature for 1 h using constant rotation. Yeasts were again washed in PBS three times and prepared as described for examination in a Hitachi H-300 electron microscope (Hitachi).
Statistical analysis. Mean values for titers of specific anti-Blastomyces antibody were expressed as reciprocal geometric mean titers (GMTs)± 1 SEM. Mean values for other parameters were given as arithmetic means± 1 SEM. The significance of differences between groups was determined with the chi-square test, or Fisher's exact test for categorical variables. The sensitivities of different assays for detection of anti-Blastomyces antibody were compared using a test of relative difference (26) . Geometric mean titers were compared using the Wilcoxon test. P-values reported are based on two-tailed levels of significance.
Results
Cell wall extracts. 25-g yeast pellets ofthe five ATCC strains of B. dermatitidis yielded a mean of 47±10 mg of extract (dry weight) after freezing (range, 20 to 70 mg), a mean of 92±9 mg after treatment with mutanolysin (range, 71 to 115 mg), and 695 mg after treatment with chitinase and fl-glucuronidase (only one strain, 60636, was extracted with the latter two enzymes). Freeze extracts had a mean protein content of 34±8% (range, 13 to 63%); extracts from mutanolysin treatment had a mean protein content of 46±10% (range, 21 to 73%); and the one from chitinase and f3-glucuronidase treatment had a protein content of 68%.
SDS-PAGE analysis showed a wide spectrum of proteins removed from the cell wall of B. dermatitidis by these extraction procedures (Fig. 1 ). Most components in the extracts stained with Coomassie blue rather than with PAS. For comparison with these extracts, we studied B-ASWS and A-antigen by SDS-PAGE. B-ASWS appeared polydispersed. A-antigen showed a major 64-kD component in addition to a large number of other bands.
Immunoblotting. Western blots were made from 10% SDS-PAGE gels loaded with 25 mg of a given cell wall extract either pooled between several strains or from a representative strain of B. dermatitidis. Sera from patients with blastomycosis or histoplasmosis or from healthy persons were used to that the molecule of interest resolved at 120±5 kD in strain 60636, however, slight variability in expression and size was noted among the five ATCC strains studied (Fig. 4) . Integration of the densitometry readings showed that the 120-kD molecule comprised 5%' of the total protein present in the crude freeze extract of strain 60636.
Boiling the crude extract at 1000C for 15 min or storing it at -20'C'either as a lyophilized powder or dissolved in treatment buffer did not appreciably alter the integrity of the 120-kD molecule as judged by SDS-PAGE. However, when several large batches of freeze extract were concentrated at 40'C using a YM 100 filter (Amicon Corp.) before dialysis and lyophilization, the intensity of the band corresponding to WI-1 on SDS-PAGE gels loaded with the resultant material was diminished and the apparent molecular weight of WI-1 decreased to as low as 1 5 kD.
EM and IFA and immunogold staining helped to identify the cell wall location of the 1 20-kD molecule. Freezing roughened' the cell wall surface morphologically but did not appear to compromise its integrity (Fig. 5) Single sera were available for 35 of the 68 patients with blastomycosis; a median ofthree sera per patient (range, 1 to 9) were available for the remaining 33 patients. Single sera were available for patients with other mycoses and healthy persons. An antibody titer of 1:40 or greater was detected in 58 (85%) ofthe 68 patients with blastomycosis, but in only 2 (3%) of the 73 patients with other mycoses (P < 1 X 10-8) and in none of the 44 healthy persons (P < 1 X 10-8) (Fig. 7) . The reciprocal GMT ofantibody in patients with blastomycosis was 2,981 ± 1, whereas the titers in the two seropositive patients with histoplasmosis were 86 and 91, respectively. One of these patients had acute pulmonary infection and no clinical information was available in the other patient. From the results presented, the sensitivity, specificity, and positive and negative predictive values of detection of antibody to WI-l by RIA are 85%, 98%, 97%, and 92%, respectively. If the positive cutoff value is increased from a titer of 1:40 to a titer of 1:100 (a value just above both seropositive controls with histoplasmosis), all cases remain seropositive and the respective measures of the test would be 85%, 100%, 100%, and 92%.
The sensitivity of the RIA for detection of antibody to WI-1 was compared to that of an enzyme immunoassay for detection of antibody to A antigen; 76 sera from 38 of the patients with blastomycosis were available for testing. Each serum specimen had been tested previously in two other studies for antibody to A antigen by enzyme immunoassay (8, 13) and was tested in the present study only for antibody to WI-I by RIA. Of these sera evaluated sequentially by both tests, 82%
were seropositive when tested by RIA in this study, whereas only 58% had been considered seropositive when tested by enzyme immunoassay previously (P < 0.0001) (Fig. 8) . The reciprocal GMTs for these assays were 1,871±1 and 19+1, respectively (P < 0.0001). The pattern of acquisition and clearance of antibody to WI-I was studied in 35 patients with a known day of onset of illness; 63 sera were tested. Antibody was usually detected by 25 d after illness onset (GMT, 349±13), titers rose gradually between 26 and 50 d after onset (GMT, 973±4), peaked between 51 and 75 d after onset (GMT, 5,324±3), fell gradually between 76 and 150 d after onset (GMT, 1,941 ± 10), and were often barely detected by 175 d after onset (GMT, 109±7). The pattern of seroresponse varied with different clinical forms of blastomycosis among the 19 patients with known date ofonset of illness or initiation oftreatment and serial sera tested (Table  II) . Patients with acute pulmonary forms of disease, which are usually seen during epidemics, may have detectable antibody at the time of onset but often do not. In contrast, patients with subacute or chronic pulmonary or extrapulmonary forms of disease usually have detectable antibody at the time of presentation, and titers tend to be higher in patients with both pulmonary and extrapulmonary involvement. Patients with isolated cutaneous disease usually had undetectable titers of antibody throughout the duration of illness and treatment.
Determination of the quantity of WI-I on B. dermatitidis and other yeasts. To generate a standard antigen-inhibition curve, we measured the amount of specific binding ofimmune rabbit serum to '25I-WI- 1 
Discussion
In this study, we investigated B. dermatitidis yeast cell walls for immunologically relevant molecules using several extraction techniques, SDS-PAGE, and immunoblotting with infected patient sera. We successfully isolated and partially purified and characterized a cell wall antigen, which we have termed WI-1.
WI-I is abundantly expressed on B. dermatitidis yeasts. It was The RIA we describe offers a significant advance for serological studies of blastomycosis. When results of the RIA for detection of antibody to WI-1 are compared to those reported using an enzyme immunoassay for detection of antibody to A antigen (8, 13) , several observations can be made: (a) antibody to WI-1 can be detected earlier, occasionally even at the onset of acute pulmonary illness; (b) antibody titers to WI-l are far higher, the GMT is -2.5 logs greater; and (c) antibody to WI-I persists for a longer interval, although antibody to both antigens declines to low or undetectable levels by 6 mo after illness onset in patients with resolution or successful treatment of disease (8) . We recognize that caution should be used in drawing conclusions about the relative sensitivities of the two tests for detection of antibody in blastomycosis, since the assays were not run in parallel in this study. Despite the high sensitivity of the RIA, specificity was not a significant problem; however, the number of patients with heterologous fungal infections tested was admittedly small. Two patients with serologically confirmed histoplasmosis did have antibody titers to WI-I just above the positive cutoff value of 1:40. However, increasing the cutoff value to 1:100 completely discriminated patients with blastomycosis from those with histoplasmosis without reducing the sensitivity or predictive values of the assay.
WI (27) . However, in contrast to WI-1, serological determinants on that molecule reside in carbohydrate moieties, which account for most (55%) ofthe molecule (27) . It is surprising that although chemotype 2 strains of H. capsulatum and strains ofB. dermatitidis share a number ofstructural features of the cell wall (28, 29) , it is the structurally dissimilar chemotype 1 strain that expresses a 120-kD molecule. Chemotype 1 strains are found principally in Central America and infrequently in North America (30) . An alternative explanation for the low-level cross-reactivity seen in our two patients with histoplasmosis might be the impurities that remained in partially purified WI-1. These were evident in silver stains of some WI-1 eluates. A high molecular weight, heat stable (100IC) factor known as "Heiner's C" (31), which is a galactomannan common to B. dermatitidis, H. capsulatum, and Paracoccidiodes brasiliensis (32) , has been linked to the cross-reactivity seen in purified preparations ofH and M components from H. capsulatum (33) . Finally, we cannot exclude the possibility that the two patients were previously infected with B. dermatitidis, since they resided in co-endemic areas and clinical information concerning blastomycosis was not ascertained.
We believe that WI-l offers important advantages over A antigen for serodiagnosis. A-antigen is a highly complex, impure material that has not been extensively characterized. The potency of A-antigen varies between lots and no reliable method of standardization is available. One study of purified A-antigen demonstrated at least 25 protein and glycoprotein bands by Coomassie blue, periodic acid-Schiff, and silver staining (5) . Although that study indicated that the activity of A-antigen was associated with two components, the molecular weights of the components were not described. A-antigen is believed to be a product of the yeast cell wall; however, this also remains uncertain (3, 5) . In contrast to A-antigen, WI-1 appears to be a nearly homogeneous preparation of a single molecule whose molecular weight and location we have clearly demonstrated. The fact that WI-l is almost entirely protein should enable the protein content and activity of the antigen from different lots to be standardized. WI-I is also easily and rapidly obtained from B. dermatitidis yeasts, albeit in small amounts. We have found, however, that freezing and thawing yeasts up to two to three times may significantly enhance the yield of WI-l (data not shown).
The superficial location of WI-I on B. dermatitidis makes this molecule readily accessible during the host-parasite, cellcell interaction and it is possible that WI-1 is recognized by the cellular immune system in patients with blastomycosis. In a preliminary experiment, the crude extract obtained from freezing and thawing B. dermatitidis yeast strain ATCC 60636 elicited lymphocyte blastogenesis in an infected mouse and human, albeit to a lesser extent than did B-ASWS (data not shown), a complex mixture of lipid, polysaccharide and protein with a molecular weight range of 30,000 to 50,000 (34) . B-ASWS contains possibly three or four components (6) . One fraction confers the high sensitivity and specificity, whereas the others appear to account for cross-reactivity with heterologous fungi, particularly H. capsulatum. Because immunologically active components in B-ASWS derive from the most superficial location of the yeast cell wall (alkali extraction is most active at the outer cell wall layer due to cleavage of a-1,3-glucan linkages), these components may share determinants on the WI-1 molecule. Features of WI-1 such as its abundant expression and superficial location on yeasts and the purity of isolated preparations suggest that its availability might contribute substantially to studies of the cellular basis for immune recognition, regulation, and control of B. dermatitidis and other pathogenic yeasts.
